619 related articles for article (PubMed ID: 17466972)
1. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
[TBL] [Abstract][Full Text] [Related]
2. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
[TBL] [Abstract][Full Text] [Related]
3. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
[TBL] [Abstract][Full Text] [Related]
5. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
[TBL] [Abstract][Full Text] [Related]
6. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK
J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
[TBL] [Abstract][Full Text] [Related]
7. Acquired nephrogenic diabetes insipidus.
Khanna A
Semin Nephrol; 2006 May; 26(3):244-8. PubMed ID: 16713497
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of aquaporin-2 in patients with diabetes insipidus.
Kanno K; Sasaki S; Hirata Y; Ishikawa S; Fushimi K; Nakanishi S; Bichet DG; Marumo F
N Engl J Med; 1995 Jun; 332(23):1540-5. PubMed ID: 7537863
[TBL] [Abstract][Full Text] [Related]
9. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
Moosavi SM; Haghani M
Can J Physiol Pharmacol; 2010 Dec; 88(12):1191-201. PubMed ID: 21164566
[TBL] [Abstract][Full Text] [Related]
10. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
[TBL] [Abstract][Full Text] [Related]
11. Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects.
Krag A; Bendtsen F; Pedersen EB; Holstein-Rathlou NH; Møller S
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1295-300. PubMed ID: 18753292
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B decreases adenylyl cyclase activity and aquaporin-2 expression in rat kidney.
Kim SW; Yeum CH; Kim S; Oh Y; Choi KC; Lee J
J Lab Clin Med; 2001 Oct; 138(4):243-9. PubMed ID: 11574818
[TBL] [Abstract][Full Text] [Related]
13. Disordered water channel expression and distribution in acquired nephrogenic diabetes insipidus.
Marples D; Frøkiaer J; Knepper MA; Nielsen S
Proc Assoc Am Physicians; 1998; 110(5):401-6. PubMed ID: 9756090
[TBL] [Abstract][Full Text] [Related]
14. Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers.
Walker RJ; Weggery S; Bedford JJ; McDonald FJ; Ellis G; Leader JP
Kidney Int; 2005 Jan; 67(1):291-4. PubMed ID: 15610254
[TBL] [Abstract][Full Text] [Related]
15. Regulation of aquaporin-2 trafficking.
Nedvetsky PI; Tamma G; Beulshausen S; Valenti G; Rosenthal W; Klussmann E
Handb Exp Pharmacol; 2009; (190):133-57. PubMed ID: 19096775
[TBL] [Abstract][Full Text] [Related]
16. Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.
Dousa TP; Valtin H
J Clin Invest; 1974 Sep; 54(3):753-62. PubMed ID: 4368480
[TBL] [Abstract][Full Text] [Related]
17. Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome.
Watanabe H; Lau DC; Guyn HL; Wong NL
Clin Invest Med; 1997 Aug; 20(4):211-23. PubMed ID: 9258576
[TBL] [Abstract][Full Text] [Related]
18. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus.
Jackson BA; Edwards RM; Valtin H; Dousa TP
J Clin Invest; 1980 Jul; 66(1):110-22. PubMed ID: 6249843
[TBL] [Abstract][Full Text] [Related]
19. [Nephrogenic diabetes insipidus].
Ishikawa S
Nihon Rinsho; 1996 Mar; 54(3):819-24. PubMed ID: 8904243
[TBL] [Abstract][Full Text] [Related]
20. Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality.
Ge Y; Ahn D; Stricklett PK; Hughes AK; Yanagisawa M; Verbalis JG; Kohan DE
Am J Physiol Renal Physiol; 2005 May; 288(5):F912-20. PubMed ID: 15632412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
